Kyle Piskel, CFO of Adaptive Biotechnologies ADPT, has filed 0 purchases and 16 sales on the open market. Over the past 12 months that comes to a net sale of $3.6M. The latest trade was on 05/18.

KP

KP

Kyle Piskel

CFO

Company

Adaptive Biotechnologies ADPT

First filing

23/03/08

Trades

34 trades

Buys / sales

0 / 16

12-month net buying

−$3.6M

Last trade

05/18

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Adaptive BiotechnologiesADPT	Open-market sale	05/18	05/20	3,115 sh	$13.04	$40,619.6	−1.2%
Adaptive BiotechnologiesADPT	Open-market sale	03/11	03/13	18,672 sh	$13.17	$245,910.24	−6.7%
Adaptive BiotechnologiesADPT	Open-market sale10b5-1 plan	02/04	02/06	2,145 sh	$18.46	$39,596.7	−1.0%
Adaptive BiotechnologiesADPT	Open-market sale10b5-1 plan	01/12	01/14	4,290 sh	$18.00	$77,220	−1.9%
Adaptive BiotechnologiesADPT	Open-market sale10b5-1 plan	25/11/28	25/12/02	162,820 sh	$19.50	$3,174,990	−42.9%
Adaptive BiotechnologiesADPT	Open-market sale	25/11/17	25/11/18	238 sh	$14.05	$3,343.9	−0.1%
Adaptive BiotechnologiesADPT	Open-market saleAmendment	25/05/16	25/05/20	1,929 sh	$8.89	$17,148.81	−0.7%
Adaptive BiotechnologiesADPT	Open-market sale	25/05/16	25/05/19	1,929 sh	$8.89	$17,148.81	−0.7%
Adaptive BiotechnologiesADPT	Open-market sale	25/03/05	25/03/06	10,320 sh3 trades	$6.98avg.	$72,072.21	−3.7%
Adaptive BiotechnologiesADPT	Open-market sale	24/11/18	24/11/19	248 sh	$4.98	$1,235.04	−0.2%
Adaptive BiotechnologiesADPT	Open-market sale	24/03/05	24/03/06	7,727 sh	$3.43	$26,503.61	−5.9%
Adaptive BiotechnologiesADPT	Open-market sale	23/11/16	23/11/20	259 sh	$4.13	$1,069.67	−0.3%
Adaptive BiotechnologiesADPT	Open-market sale	23/03/06	23/03/08	3,529 sh2 trades	$8.57avg.	$30,245.82	−3.9%